Buradasınız

Anasayfa » Content

Factors Affecting the Production of Drugs in Our Pharmaceutical Companies; A Case Study of Ilorin Metropolis

Journal Name:

  • International Journal of Science and Engineering Investigations

Publication Year:

  • 2013

Key Words:

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The scope of this research concerns itself with the problem facing production of drugs in our pharmaceutical companies. The instrument used for the study is a twenty-five (25) item questionnaire, which demanded information such as staff factor, quality assurance factor and material factor provided for research work. A total number of one hundred and sixty (160) staff from four selected pharmaceutical companies in Ilorin metropolis completed the questionnaire. The data obtained was analysed using frequency counts, percentages and rank-ordering. The result obtained showed that there is problem on drug production in pharmaceutical companies regardless of the company status. It is on this basis that recommendations such as employing qualified staff, providing physical infrastructures such as environmental control and providing quality testing laboratories for batch samples were made.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon ijsei-21713-05.pdf
  • 17
24-27
  • English

REFERENCES

References: 

[1] M. Philips. “Advanced Chemistry”. Cambridge. University of Cambridge Press. Pp 155-168, 1992
[2] R. Arthur, and A. Delong. “Drug Research: A foundation for decision making”. New York. Springfield press. Pp 144-150, 1979.
[3] J. Michael. “Drugs and the Special Child”. New York. Wiley. Pp 45-70, 1979.
[4] G. Biemba. “Problem analysis of drug production”. Zambia. Lusaka Press, 2005.
[5] H. P. Bollinger. “Research Pharmaceutique Ecumenique”. Journal of Educational Psychology. Vol. 18, pp 10-15, 2004.
[6] A. Akinyemi. “Drug Supplying Organisation for storage and Management capacities”. Journal of medical sciences”. Vol. 10. Pp 16-18, 2005.
[7] World Health Organization. “A report of the feedback meeting on Guidelines for effective and efficient pharmaceutical services in Nairobi”. Pp 3-7, 2004.
[8] J. Am. “Trends in the production of drugs development research. Journal of National Institute of Health”. Vol. 4 (1): pp 46-54, 1997.

Thank you for copying data from http://www.arastirmax.com